↓ Skip to main content

Age-related frailty and its association with biological markers of ageing

Overview of attention for article published in BMC Medicine, July 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

blogs
1 blog
twitter
28 X users
wikipedia
1 Wikipedia page
reddit
1 Redditor

Citations

dimensions_citation
244 Dimensions

Readers on

mendeley
244 Mendeley
Title
Age-related frailty and its association with biological markers of ageing
Published in
BMC Medicine, July 2015
DOI 10.1186/s12916-015-0400-x
Pubmed ID
Authors

Arnold Mitnitski, Joanna Collerton, Carmen Martin-Ruiz, Carol Jagger, Thomas von Zglinicki, Kenneth Rockwood, Thomas B. L. Kirkwood

Abstract

The relationship between age-related frailty and the underlying processes that drive changes in health is currently unclear. Considered individually, most blood biomarkers show only weak relationships with frailty and ageing. Here, we examined whether a biomarker-based frailty index (FI-B) allowed examination of their collective effect in predicting mortality compared with individual biomarkers, a clinical deficits frailty index (FI-CD), and the Fried frailty phenotype. We analyzed baseline data and up to 7-year mortality in the Newcastle 85+ Study (n = 845; mean age 85.5). The FI-B combined 40 biomarkers of cellular ageing, inflammation, haematology, and immunosenescence. The Kaplan-Meier estimator was used to stratify participants into FI-B risk strata. Stability of the risk estimates for the FI-B was assessed using iterative, random subsampling of the 40 FI-B items. Predictive validity was tested using Cox proportional hazards analysis and discriminative ability by the area under receiver operating characteristic (ROC) curves. The mean FI-B was 0.35 (SD, 0.08), higher than the mean FI-CD (0.22; SD, 0.12); no participant had an FI-B score <0.12. Higher values of each FI were associated with higher mortality risk. In a sex-adjusted model, each one percent increase in the FI-B increased the hazard ratio by 5.4 % (HR, 1.05; CI, 1.04-1.06). The FI-B was more powerful for mortality prediction than any individual biomarker and was robust to biomarker substitution. The ROC analysis showed moderate discriminative ability for 7-year mortality (AUC for FI-CD = 0.71 and AUC for FI-B = 0.66). No individual biomarker's AUC exceeded 0.61. The AUC for combined FI-CD/FI-B was 0.75. Many biological processes are implicated in ageing. The systemic effects of these processes can be elucidated using the frailty index approach, which showed here that subclinical deficits increased the risk of death. In the future, blood biomarkers may indicate the nature of the underlying causal deficits leading to age-related frailty, thereby helping to expose targets for early preventative interventions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 244 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Unknown 243 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 40 16%
Student > Ph. D. Student 39 16%
Student > Bachelor 26 11%
Other 21 9%
Student > Doctoral Student 19 8%
Other 45 18%
Unknown 54 22%
Readers by discipline Count As %
Medicine and Dentistry 65 27%
Biochemistry, Genetics and Molecular Biology 20 8%
Nursing and Health Professions 16 7%
Agricultural and Biological Sciences 14 6%
Immunology and Microbiology 8 3%
Other 43 18%
Unknown 78 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2021.
All research outputs
#1,305,529
of 25,743,152 outputs
Outputs from BMC Medicine
#904
of 4,083 outputs
Outputs of similar age
#15,692
of 276,789 outputs
Outputs of similar age from BMC Medicine
#19
of 75 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,083 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,789 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.